Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. April 2014 11:12 ET | Quelle: Kane Biotech Inc.

Kane Biotech Appoints Dr. Sarah Prichard, M.D. to the Board of Directors

WINNIPEG, MANITOBA--(Marketwired - April 2, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company developing and commercializing products that prevent and remove microbial...
01. April 2014 15:41 ET | Quelle: Kane Biotech Inc.

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, MANITOBA--(Marketwired - April 1, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced that it has issued 118,383 common shares of the Corporation...
26. März 2014 10:30 ET | Quelle: Kane Biotech Inc.

StrixNB(TM) Powder Formulation Approved by Health Canada's LRVHP Program

WINNIPEG, MANITOBA--(Marketwired - March 26, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and...
11. März 2014 08:00 ET | Quelle: Kane Biotech Inc.

StrixNB(TM) Effective Against Cat Bite Wound Infections

WINNIPEG, MANITOBA--(Marketwired - March 11, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
04. Februar 2014 08:00 ET | Quelle: Kane Biotech Inc.

Kane Biotech Receives $397,500 From Warrant Exercise

WINNIPEG, MANITOBA--(Marketwired - Feb. 4, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
07. Januar 2014 08:00 ET | Quelle: Kane Biotech Inc.

DispersinB(R) Topical Spray Approval from Health Canada's LRVHP Program

WINNIPEG, MANITOBA--(Marketwired - Jan. 7, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
18. Dezember 2013 17:57 ET | Quelle: Kane Biotech Inc.

Kane Biotech Announces Closing of Private Placement Offering

WINNIPEG, MANITOBA--(Marketwired - Dec. 18, 2013) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced that the Corporation has closed its previously announced...
17. Dezember 2013 08:00 ET | Quelle: Kane Biotech Inc.

Kane Biotech Signs Option Agreement With Global Health Care Company

WINNIPEG, MANITOBA--(Marketwired - Dec. 17, 2013) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
06. Dezember 2013 08:00 ET | Quelle: Kane Biotech Inc.

Kane Biotech Announces Extension of Warrants and Private Placement Offering

WINNIPEG, MANITOBA--(Marketwired - Dec. 6, 2013) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced that it has amended the terms of its 18,035,000 share purchase warrants...
06. November 2013 08:00 ET | Quelle: Kane Biotech Inc.

New StrixNB(TM) Pet Oral Care Approval from Heath Canada's LRVHP Program

WINNIPEG, MANITOBA--(Marketwired - Nov. 6, 2013) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...

Vorherige Seite